Acute kidney injury: the experience of a tertiary center of Pediatric Nephrology.


Journal

Jornal brasileiro de nefrologia
ISSN: 2175-8239
Titre abrégé: J Bras Nefrol
Pays: Brazil
ID NLM: 9426946

Informations de publication

Date de publication:
2024
Historique:
received: 21 01 2024
accepted: 12 03 2024
medline: 15 5 2024
pubmed: 15 5 2024
entrez: 15 5 2024
Statut: epublish

Résumé

Acute kidney injury (AKI) is an abrupt deterioration of kidney function. The incidence of pediatric AKI is increasing worldwide, both in critically and non-critically ill settings. We aimed to characterize the presentation, etiology, evolution, and outcome of AKI in pediatric patients admitted to a tertiary care center. We performed a retrospective observational single-center study of patients aged 29 days to 17 years and 365 days admitted to our Pediatric Nephrology Unit from January 2012 to December 2021, with the diagnosis of AKI. AKI severity was categorized according to Kidney Disease Improving Global Outcomes (KDIGO) criteria. The outcomes considered were death or sequelae (proteinuria, hypertension, or changes in renal function at 3 to 6 months follow-up assessments). Forty-six patients with a median age of 13.0 (3.5-15.5) years were included. About half of the patients (n = 24, 52.2%) had an identifiable risk factor for the development of AKI. Thirteen patients (28.3%) were anuric, and all of those were categorized as AKI KDIGO stage 3 (p < 0.001). Almost one quarter (n = 10, 21.7%) of patients required renal replacement therapy. Approximately 60% of patients (n = 26) had at least one sequelae, with proteinuria being the most common (n = 15, 38.5%; median (P25-75) urinary protein-to-creatinine ratio 0.30 (0.27-0.44) mg/mg), followed by reduced glomerular filtration rate (GFR) (n = 11, 27.5%; median (P25-75) GFR 75 (62-83) mL/min/1.73 m2). Pediatric AKI is associated with substantial morbidity, with potential for proteinuria development and renal function impairment and a relevant impact on long-term prognosis.

Identifiants

pubmed: 38748945
pii: S0101-28002024000300305
doi: 10.1590/2175-8239-JBN-2024-0012en
pii:
doi:

Types de publication

Journal Article Observational Study

Langues

eng por

Sous-ensembles de citation

IM

Pagination

e20240012

Auteurs

Carolina Silva Figueiredo (CS)

Hospital do Divino Espírito Santo de Ponta Delgada, Serviço de Pediatria, Ilha de São Miguel, Portugal.

Ana Margarida Neto da Rocha (AMND)

Universidade do Porto, Instituto de Ciências Biomédicas Abel Salazar, Porto, Portugal.

Liane Maria Correia Rodrigues da Costa Nogueira Silva (LMCRDCN)

Universidade do Porto, Instituto de Ciências Biomédicas Abel Salazar, Porto, Portugal.
Centro Hospitalar Universitário de Santo António, Centro Materno-Infantil do Norte, Unidade de Nefrologia Pediátrica, Porto, Portugal.
Universidade do Porto, Instituto de Saúde Pública (EPIUnit), Porto, Portugal.
Universidade do Porto, Laboratório para a Investigação Integrativa e Translacional em Saúde Populacional (ITR), Porto, Portugal.

Maria do Sameiro Pinto César de Faria (MDSPC)

Centro Hospitalar Universitário de Santo António, Centro Materno-Infantil do Norte, Unidade de Nefrologia Pediátrica, Porto, Portugal.
Universidade do Porto e Universidade NOVA de Lisboa, Unidade de Ciências Biomoleculares Aplicadas (UCIBIO), Lisboa, Portugal.

Teresa Maria Tavares Vieira da Costa Tavares (TMTVDC)

Centro Hospitalar Universitário de Santo António, Centro Materno-Infantil do Norte, Unidade de Nefrologia Pediátrica, Porto, Portugal.

Maria da Conceição Oliveira Costa Mota (MDCOC)

Centro Hospitalar Universitário de Santo António, Centro Materno-Infantil do Norte, Unidade de Nefrologia Pediátrica, Porto, Portugal.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH